Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN118207554A reveals green electro-oxidative synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN118638117B reveals green synthesis for MRI intermediates. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing partners globally.
Patent CN120136859A reveals a novel binaphthyl ligand for synthesizing high-purity seven-membered nitrogen heterocycles, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN103288757A reveals a novel solid-acid catalyzed nitration route for key TKI intermediates, offering significant cost reduction and simplified supply chains for pharmaceutical manufacturers.
Patent CN103524359B reveals high ee value synthesis using epichlorohydrin. Offers significant cost reduction and supply reliability for asymmetric catalysis manufacturing processes.
Patent CN103130862B reveals a safer synthesis route for ulipristal acetate intermediates, offering significant supply chain stability and cost reduction benefits for pharmaceutical manufacturing.
Patent CN101891647A details a novel Ubenimex preparation using L-lysine resolution and EDCI/HOAt coupling, ensuring >99.5% purity and robust supply chain reliability.
Patent CN107531680B reveals a novel route for toxin intermediates, offering high optical purity and yield for cost reduction in ADC toxin manufacturing.
Patent CN115073250A reveals a mild visible-light method for sp3 C-F bond carboxylation. Discover cost-effective routes for high-purity pharmaceutical intermediates.
Patent CN113527304B details novel quinoline synthesis enabling high purity pharmaceutical intermediates with optimized supply chain continuity and cost efficiency.
Patent CN101830961A details novel ursolic acid esters with enhanced antitumor activity via efficient Claisen-Schmidt condensation and esterification routes suitable for scale-up.
Novel water-based synthesis for Kasaran offers high purity and yield. Reduces environmental impact and cost for pharmaceutical intermediates manufacturing supply chain.
Analysis of patent CN105130842B reveals a novel heterogeneous catalyst for chiral amino alcohol synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN113845436B reveals a metal-free photocatalytic method for defluorination, offering cost reduction and scalable synthesis for high-purity fluorinated intermediates.
Patent CN110256365B reveals a green dichlorotitanocene-catalyzed route for benzodiazepines, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN115557900A details a mild Rh-catalyzed route to 3-substituted pyridazines with quaternary centers, offering high efficiency for reliable pharmaceutical intermediate suppliers.
Patent CN101824038B details a high-yield Pd/C and iodine-catalyzed route for camptothecin analogues, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN110194724B introduces diphenylmethane carriers for peptide synthesis, offering high purity, simplified extraction, and scalable manufacturing for reliable pharmaceutical intermediate supply.
Patent CN108409743A details mild oxidative cyclization using oxygen. This method offers substantial cost reduction and supply chain reliability for pharmaceutical manufacturing partners seeking scalable intermediates.
Patent CN116496189B reveals copper-catalyzed synthesis of N-acyl sulfenamides. Enables efficient asymmetric disulfide production for ADCs and pharmaceutical intermediates with mild conditions.